Area of research
Hematology · Molecular Biology
Research interest
Research focused on Cancer research and Multiple myeloma, with related work in Chronic myelogenous leukemia, Ground-penetrating radar, Refractory (planetary science). Notable publications include 'Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis', 'Reconstruction and prediction of tunnel surrounding rock deformation data based on PSO optimized LSSVR and GPR models', and 'Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open‐label study'.
Acevaltrate overcomes myeloma resistance to bortezomib via pyroptosis by promoting BAX translocalization to mitochondria
Reconstruction and prediction of tunnel surrounding rock deformation data based on PSO optimized LSSVR and GPR models
Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma
A novel and selective oral PI3Kα/δ inhibitor, TQ-B3525, in patients with relapsed and/or refractory follicular lymphoma: A phase II, single-arm, open-label study.
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open‐label study
Inhibition of USP10 induces myeloma cell apoptosis by promoting cyclin D3 degradation
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial
Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis